Below is a non-exhaustive list of organizations that support individuals with neuroimmunologic conditions. Many provide resources for multiple diagnoses beyond their primary focus.

Orange button with a downward pointing arrow symbol.

National MS Society (NMSS)

A leading organization offering education, support services, and research funding for the MS community.

Multiple Sclerosis Association of America (MSAA)

Provides MRI assistance, educational materials, cooling gear, and direct support for individuals with MS.

MS Foundation

Dedicated to empowering people with MS through outreach, education, and supportive services.

The Sumaira Foundation

Founded by a patient, this nonprofit focuses on advocacy, education, and support for those with NMOSD and MOGAD.

The Guthy-Jackson Charitable Foundation

Focused on advancing research, treatments, and awareness for NMOSD.

AE Alliance

Supports patients and families affected by autoimmune encephalitis through awareness, education, and research.

Find a Neuroimmunology Specialist

If you’re newly diagnosed or exploring care options, this directory is a great place to start. It features neurologists with deep expertise in neuroimmunology—many of whom have completed advanced fellowships and care for complex cases every day. You'll also find nurse practitioners and other essential care team members who play a critical role in supporting patients throughout their journey.

Whether you're seeking a referral or simply want to learn more about the specialists in your area, we’re here to help you make informed decisions about your care.

Not listed yet? We'd love to include you. Get in touch.

Explore ongoing clinical trials in neuroimmunology and MS-related conditions throughout the Chicagoland region. Each site below lists current studies, the principal investigators (PIs), and coordinator contacts for enrollment or more information.

  • Principal Investigator: William L. Conte, MD, MS ||| Study Coordinator: Michelle Ham, RN – mham@methodisthospitals.org

    REMODEL-2 – Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis

    FREXALT – Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

    FREVIVA – Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis

  • Principal Investigator: Carolyn Goldschmidt, DO ||| Study Coordinator: May Navamon Aunaetitrakul – naunaetitrakul@northshore.org

    SOSTOS – A randomized, open label, multi-center, active-comparator study to assess the efficacy, safety and tolerability of ofatumumab 20mg sc monthly versus continued current therapy in relapsing-remitting multiple sclerosis after elevation of serum neurofilament light levels

    Principal Investigator: Afif Hentati, MD ||| Study Coordinator: May Navamon Aunaetitrakul – naunaetitrakul@northshore.org

    FREXALT– Master protocol of two Phase 3, randomized, double-blind efficacy and safety studies comparing frexalimab (SAR441344) to teriflunomide (Aubagio) in adult participants with relapsing forms of multiple sclerosis

    Principal Investigator: Afif Hentati, MD ||| Study Coordinator: Martha Cruz – mcruz8@northshore.org

    OPTIS – Performance and safety of a digital tool for the unsupervised self-assessment of neuromyelitis optica spectrum disorder

    Principal Investigator: Carolyn Goldschmidt, DO ||| Study Coordinator: May Navamon Aunaetitrakul – naunaetitrakul@northshore.org

    ENABLE – to evaluate safety, effectiveness, and to gain insight into the treatment experience of participants prescribed BRIUMVI® (ublituximab-xiiy) in the real-world setting

  • Principal Investigator: Tom Shoemaker, MD ||| Study Coordinator: Becca McWilliams – rebecca_mcwilliams@rush.edu

    REMODEL-2 – Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis

    TREAT-MS – Traditional Versus Early Aggressive Therapy for Multiple Sclerosis

    FREVIVA– Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis

    OAK – Comparison Between ABP 692 and Ocrevus

    Principal Investigator: Tom Shoemaker, MD ||| Study Coordinator: Liz Dvorak – elizabeth_dvorak@rush.edu

    ENHANCE – Study to Evaluate Efficacy of a Modified Regimen of Ublituximab

    Principal Investigator: Fabian Sierra-Morales, MD ||| Study Coordinators: Jules Skoda julia_l_skoda@rush.edu   & Becca McWilliams rebecca_mcwilliams@rush.edu

    ENABLE – A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis

    Principal Investigator: Allison Osen, MD ||| Study Coordinator: Becca McWilliams – rebecca_mcwilliams@rush.edu

    CLOU064C12306 – A randomized, open-label, parallel-group, non-inferiority study comparing efficacy, safety, and tolerability of remibrutinib after switching from ocrelizumab in participants living with relapsing multiple sclerosis, followed by open-label treatment with remibrutinib.

  • Principal Investigator: Edith Graham, MD ||| Study Coordinator: Irena Bellinski, RN – irena.bellinski@nm.org

    KATHAROS – Effect of Kesimpta in lactating women with MS

    Principal Investigator: Dr. George Georges | Neurology Investigator: Dr. Bruce Cohen ||| Study Coordinator: Matthew Selle – matthew.selle@nm.org

    BEAT-MS – Best Available Therapy Versus Autologous Hematopoetic Stem Cell Transplant for Multiple Sclerosis

    Principal Investigator: Dr. Elena Grebenciucova ||| Study Coordinator: Monika Szela – monika.szela@northwestern.edu

    ExTINGUISH – Trial of Inebilizumab in NMDAR Encephalitis 

  • Principal Investigator: Dr. Veronica Cipriani

    FREVIVA – Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis

  • Study Coordinator: Alison Wathen – awathe2@uic.edu

    METS for MS – Mood and Exercise Training Study for Multiple Sclerosis

    Study Coordinator: Peixuan Zheng – pacems@uic.edu

    PACE MS – Cognition, Vascular Function, and Physical Activity in Multiple Sclerosis

    Study Coordinator: Brenda Jeng – enrl@uic.edu

    Walking Efficiency and Vascular Function in Multiple Sclerosis

    Study Coordinator: Ilaria Santi – isanti@uic.edu

    Randomized Pilot Study Evaluating the Effect of a 6-Month Exercise Rehabilitation Program on Physical and Cognitive Function in Persons with MS who Use Wheelchairs as a Primary Mobility Device

    Study Coordinator: Victoria Flores – realms@uic.edu

    REAL MS – Race, Ethnicity, and Active Lifestyle in MS

    Study Coordinator: Emily Barron – bipamscognition@uic.edu

    BIPAMS-C – Behavioral Intervention for Physical Activity in Multiple Sclerosis – Cognition

    Study Coordinator: Petra Silic – enrl@uic.edu

    PAW-MS-GAD – Physical Activity in Women with Multiple Sclerosis and Generalized Anxiety Disorder

    Study Coordinator: Louise Declerck – enrl@uic.edu

    Knowledge and Perceptions of Exercise Training Among People Living with Multiple Sclerosis